A Dark Vector Cognition product

Item 5. OTHER ITEMS

2K characters. Original on sec.gov · Markdown

Item 5. OTHER ITEMS

(c) Director and Officer Trading Arrangements

During the three months ended March 31, 2024, no director or officer of the company adopted, modified or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K, except as provided below.

Name & TitleAction TakenDate AdoptedType of Trading Arrangement**(1)**Aggregate Number of Shares to be Sold Pursuant to Trading ArrangementDuration of Trading Arrangement**(2)**
Richard A. Gonzalez Chairman of the Board and Chief Executive OfficerAdoption03/26/2024Rule 10b5-1 Trading ArrangementUp to 282,845 Shares Issuable Upon the Exercise of Options12/31/2024
  1. Except as indicated by footnote, each trading arrangement marked as a "Rule 10b5-1 Trading Arrangement" is intended to satisfy the affirmative defense of Rule 10b5-1(c), as amended.

  2. Except as indicated by footnote, each trading arrangement permitted or permits transactions through and including the earlier to occur of (a) the completion of all sales or (b) the date listed in the table. Each trading arrangement marked as a “Rule 10b5-1 Trading Arrangement” only permitted or only permits transactions upon expiration of the applicable mandatory cooling-off period under the Rule.

2024 Form 10-Q | abbvieimage2a21.gif40

Previous: Item 4. CONTROLS AND PROCEDURES · Next: Item 6. EXHIBITS